Two weeks into the Trump administration, external communication from federal health agencies, including the Centers for ...

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV ...

GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

The United States' recent announcement to withdraw from the World Health Organization (WHO) has raised concerns across the global health community, particularly regarding the potential disruption of ...

President Trump’s pause on aid, and the gutting of the primary aid agency, could jeopardize the health of more than 20 ...

Republicans on the Senate Finance Committee voted to move forward with Trump's nominee to run Health and Human Services (HHS) ...

The pharmaceutical giant is now targeting more than £40billion in annual revenue by 2031, compared to a previous outlook of £38billion.

After Donald Trump gave orders that US would recognise only two sexes, references to LGBT health, HIV, and information on ...

GSK has today posted a better-than-expected fourth quarter and lifted its 2031 sales target to nearly $50 billion as the ...

It has been just over two weeks since President Trump took office, and there have been significant effects already on public ...

Uvax Bio, LLC, ("Uvax” or "the Company”) a privately held, clinical-stage vaccine company utilizing rational and ...

The Trump administration’s crusade to erase transgender identity from the federal government continued on Friday with a ...